Passive immunotherapy using approved vaccines combined with lockdown, as essential parts of the community medicine and public health to survive and even beat COVID: A viewpoint commentary

Main Article Content

Jerard Seghatchian*

Downloads

Download data is not yet available.

Article Details

Seghatchian, J. (2021). Passive immunotherapy using approved vaccines combined with lockdown, as essential parts of the community medicine and public health to survive and even beat COVID: A viewpoint commentary. Archives of Community Medicine and Public Health, 7(2), 074–075. https://doi.org/10.17352/2455-5479.000142
Commentaries

Copyright (c) 2021 Seghatchian J.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Seghatchian J (2020) An introductory commentary on the use of artificial intelligence, machine learning and TQM, as novel computational tools in big data patterns or procedural analysis, in transfusion medicine. Transfus Apher Sci 59: 102985. Link: https://pubmed.ncbi.nlm.nih.gov/33158743/

D'Alessandro A (2020) Benford’s law and metabolomics: a tale of numbers and blood. Transfus Apher Sci 59: 103019. Link: https://bit.ly/34vCCC6

Seghatchian J (2021) New generation of vaccines and convalescent plasma therapy for the management of CoV-2, in the global pandemic. Transfus Apher Sci 60: 103061. Link: https://bit.ly/3i2S8xd

Seghatchian J (2021) Editorial. Facts and challenges on global deployment of vaccines for the immunotherapy of the evolving SARS Cov-2 variants: What a new year, with a fast spreading South African and the most fearful Brazilian variants, as the unwanted gifts, imposing enormous crises to surmount. Link: https://bit.ly/3uw6OHS

Seghatchian J, Acker JP, Putter JS (2020) Update on newer approaches to prevent or treat COVID-19 infection: what we all need the most right now. Transfus Apher Sci 59: 102933. Link: https://bit.ly/3yMl0Qs

Seghatchian J, Lanza F (2020) Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: A rousing message of clinical benefit to both donors and recipients alike. Transfus Apher Sci 59: 102794. Link: https://bit.ly/3vB9NQH

Lanza F, Agostini V, Monaco F, Passamonti F, Seghatchian J (2021) Therapeutic use of convalescent plasma in covid-19 infected patients with concomitant hematological disorders. Clinical Hematology International Link: https://bit.ly/3c4O0sO

Putter JS, Seghatchian J (2020) An update on COVID-19 infection control measures, plasma-based therapeutics, corticosteroid pharmacotherapy and vaccine research. Transfus Apher Sci 59: 102934. Link: https://bit.ly/3vK823X

Amiral J, Vissac AM, Seghatchian J (2020) Covid-19, induced activation of hemostasis, and immune reactions: Can an auto-immune reaction contribute to the delayed severe complications observed in some patients? Transfus Apher Sci 59: 102804. Link: https://bit.ly/2RNrZbk

Alessandro D, Tiffany A, Dzieciatkowaska M, Hill RC, Richado F, et al. (2020) Serum proteomics in COVID-19 patients: altered coagulation and complement status as a function of IL-6 level. J Proteome Res 19: 4417-4427. Link: https://bit.ly/2Tvev4x

Mykhailova O, Seghatchain J, Acker J (2020) Assessment of extracellular vesicles using IFC for application in transfusion medicine. Transfus Apher Sci 59: 102942. Link: https://bit.ly/3c2aGKa

Picchianti Diamanti A, Rosado MM, Pioli C, Sesti G, Laganà B (2020) Cytokine release syndrome in COVID-19 patients, a new scenario for an old concern: The fragile balance between infections and autoimmunity. Int J Mol Sci 21: 3330. Link: https://bit.ly/3i8Ts1A

Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, et al. (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet 395: 1417-1418. Link: https://bit.ly/3fykY7k

Connors JM, Levy JH (2020) Thromboinflammation and the hypercoagulability of COVID-19. J Thromb Haemost 18: 1559-1561. Link: https://bit.ly/3ieQau7

Chen G, Zhou Y, Ma J, Xia P, Qin Y, et al. (2020) Is there a role for blood purification therapies targeting cytokine storm syndrome in critically severe COVID-19 patients? Renal Failure 42: 483-488. Link: https://bit.ly/3yLUp5U

Smit Sibinga CT, Abdella YE, Seghatchian J (2020) Poor economics - Transforming challenges in transfusion medicine and science into opportunities. Transfus Apher Sci 59: 102752. Link: https://bit.ly/3uvuDQd